{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:27:43Z","timestamp":1787668063388,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.iac.2021.09.007","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T18:10:28Z","timestamp":1637604628000},"page":"45-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Anaphylaxis and Mast Cell Disorders"],"prefix":"10.1016","volume":"42","author":[{"given":"Theo","family":"G\u00fclen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2021.09.007_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","article-title":"Mast cells as \"tunable\" effector and immunoregulatory cells: recent advances","volume":"23","author":"Galli","year":"2005","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.iac.2021.09.007_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jdermsci.2007.09.009","article-title":"Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis","volume":"49","author":"Galli","year":"2008","journal-title":"J\u00a0Dermatol Sci"},{"issue":"23","key":"10.1016\/j.iac.2021.09.007_bib3","doi-asserted-by":"crossref","first-page":"10743","DOI":"10.7150\/thno.46719","article-title":"Mast cells as a unique hematopoietic lineage and cell system: from Paul Ehrlich's visions to precision medicine concepts","volume":"10","author":"Valent","year":"2020","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.iac.2021.09.007_bib4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/ijms21020464","article-title":"Mast cells: fascinating but still elusive after 140 years from their discovery","volume":"21","author":"Varricchi","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.iac.2021.09.007_bib5","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/eji.201040559","article-title":"Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity","volume":"40","author":"Galli","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.iac.2021.09.007_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000315937","article-title":"Anaphylaxis: mechanisms of mast cell activation","volume":"95","author":"Kalesnikoff","year":"2010","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.iac.2021.09.007_bib7","first-page":"43","article-title":"Roles of adaptor molecules in mast cell activation","volume":"87","author":"Iwaki","year":"2005","journal-title":"Chem Immunol Allergy"},{"issue":"1","key":"10.1016\/j.iac.2021.09.007_bib8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaip.2019.09.038","article-title":"MRGPRX2 signaling and skin test results","volume":"8","author":"Kelso","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2021.09.007_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1615\/CritRevImmunol.v31.i6.30","article-title":"Regulation of mast cell responses in health and disease","volume":"31","author":"Gilfillan","year":"2011","journal-title":"Crit Rev Immunol"},{"issue":"3","key":"10.1016\/j.iac.2021.09.007_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.iac.2006.05.005","article-title":"Mast cell mediators in allergic inflammation and mastocytosis","volume":"26","author":"Castells","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4","key":"10.1016\/j.iac.2021.09.007_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jaci.2013.07.046","article-title":"Basophils and allergic inflammation","volume":"132","author":"Siracusa","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2021.09.007_bib12","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/cea.13117","article-title":"Important and specific role for basophils in acute allergic reactions","volume":"48","author":"Koro\u0161ec","year":"2018","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.iac.2021.09.007_bib13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S1081-1206(10)61086-1","article-title":"Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group","volume":"97","author":"Lieberman","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2021.09.007_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000315935","article-title":"Epidemiology of anaphylaxis","volume":"95","author":"Worm","year":"2010","journal-title":"Chem Immunol Allergy"},{"issue":"11","key":"10.1016\/j.iac.2021.09.007_bib15","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/all.12272","article-title":"The epidemiology of anaphylaxis in Europe: a systematic review","volume":"68","author":"Panesar","year":"2013","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2021.09.007_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaci.2013.08.016","article-title":"Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States","volume":"133","author":"Wood","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2021.09.007_bib17","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaci.2008.09.043","article-title":"The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project","volume":"122","author":"Decker","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2021.09.007_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1258\/jrsm.2008.070306","article-title":"Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England","volume":"101","author":"Sheikh","year":"2008","journal-title":"J\u00a0R Soc Med"},{"issue":"4","key":"10.1016\/j.iac.2021.09.007_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.annemergmed.2006.01.018","article-title":"Second symposium on the definition and management of anaphylaxis: summary report--second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"47","author":"Sampson","year":"2006","journal-title":"Ann Emerg Med"},{"issue":"2","key":"10.1016\/j.iac.2021.09.007_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/WOX.0b013e318211496c","article-title":"World allergy organization guidelines for the assessment and management of anaphylaxis","volume":"4","author":"Simons","year":"2011","journal-title":"World Allergy Organ J"},{"issue":"2","key":"10.1016\/j.iac.2021.09.007_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/adc.2004.069914","article-title":"Paediatric emergency department anaphylaxis: different patterns from adults","volume":"91","author":"Braganza","year":"2006","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.iac.2021.09.007_bib22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2222.2011.03954.x","article-title":"Anaphylaxis and reactions to foods in children--a population-based case study of emergency department visits","volume":"42","author":"Vetander","year":"2012","journal-title":"Clin Exp Allergy"},{"issue":"21","key":"10.1016\/j.iac.2021.09.007_bib23","first-page":"367","article-title":"Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland","volume":"111","author":"Worm","year":"2014","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"10.1016\/j.iac.2021.09.007_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1398-9995.2005.00785.x","article-title":"Epidemiology of life-threatening and lethal anaphylaxis: a review","volume":"60","author":"Moneret-Vautrin","year":"2005","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.iac.2021.09.007_bib25","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2021.09.007_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cea.12225","article-title":"High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience","volume":"44","author":"Gulen","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.iac.2021.09.007_bib27","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jaip.2017.02.008","article-title":"Risk factor analysis of anaphylactic reactions in patients with systemic mastocytosis","volume":"5","author":"Gulen","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2021.09.007_bib28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2021.09.007_bib29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaip.2014.03.007","article-title":"Mast cell activation disorders","volume":"2","author":"Akin","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2021.09.007_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/joim.12410","article-title":"Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease","volume":"279","author":"Gulen","year":"2016","journal-title":"J\u00a0Intern Med"},{"issue":"11","key":"10.1016\/j.iac.2021.09.007_bib31","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis 2016: updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.iac.2021.09.007_bib32","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jaci.2012.10.015","article-title":"Prevalence of indolent systemic mastocytosis in a Dutch region","volume":"131","author":"van Doormaal","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2021.09.007_bib33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/bjh.12916","article-title":"Epidemiology of systemic mastocytosis in Denmark","volume":"166","author":"Cohen","year":"2014","journal-title":"Br J Haematol"},{"issue":"9928","key":"10.1016\/j.iac.2021.09.007_bib34","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(14)60585-7","article-title":"Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis","volume":"383","author":"Gulen","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.iac.2021.09.007_bib35","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","article-title":"Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with \"idiopathic\" anaphylaxis","volume":"110","author":"Akin","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.iac.2021.09.007_bib36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000096442","article-title":"Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome","volume":"142","author":"Sonneck","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"issue":"4","key":"10.1016\/j.iac.2021.09.007_bib37","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaip.2019.01.006","article-title":"Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome","volume":"7","author":"Valent","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2021.09.007_bib38","article-title":"Selecting the right criteria and proper classification to diagnose mast cell activation syndromes: a critical review","volume":"22","author":"G\u00fclen","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2021.09.007_bib39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaci.2009.08.035","article-title":"Mechanisms of mast cell signaling in anaphylaxis","volume":"124","author":"Metcalfe","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1\u20133","key":"10.1016\/j.iac.2021.09.007_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12026-008-8046-9","article-title":"Amplification mechanisms for the enhancement of antigen-mediated mast cell activation","volume":"43","author":"Gilfillan","year":"2009","journal-title":"Immunol Res"},{"issue":"3","key":"10.1016\/j.iac.2021.09.007_bib41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40521-014-0021-1","article-title":"Diagnosis and treatment of anaphylaxis in patients with mastocytosis","volume":"1","author":"Valent","year":"2014","journal-title":"Curr Treat Options Allergy"},{"issue":"5","key":"10.1016\/j.iac.2021.09.007_bib42","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jaci.2013.11.039","article-title":"Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities","volume":"133","author":"Lyons","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.iac.2021.09.007_bib43","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.iac.2021.09.007_bib44","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.jaip.2020.05.057","article-title":"Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression","volume":"8","author":"Robey","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2021.09.007_bib45","first-page":"889","article-title":"Hereditary alpha tryptasemia is not associated with specific clinical phenotypes","volume":"148","author":"Chollet","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2021.09.007_bib46","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/ACI.0000000000000678","article-title":"Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia","volume":"20","author":"O'Connell","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2021.09.007_bib47","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased \u03b1-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2021.09.007_bib48","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.iac.2021.09.007_bib49","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2021.09.007_bib50","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.iac.2021.09.007_bib51","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/all.13207","article-title":"Patterns of anaphylaxis after diagnostic workup: a follow-up study of 226 patients with suspected anaphylaxis","volume":"72","author":"Oropeza","year":"2017","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2021.09.007_bib52","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2021.09.007_bib53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/all.13980","article-title":"Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protection","volume":"75","author":"Jarkvist","year":"2020","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.iac.2021.09.007_bib54","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/cea.12914","article-title":"Assessment of in\u00a0vivo mast cell reactivity in patients with systemic mastocytosis","volume":"47","author":"Gulen","year":"2017","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"10.1016\/j.iac.2021.09.007_bib55","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)","volume":"37","author":"Gonzalez de Olano","year":"2007","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.iac.2021.09.007_bib56","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000348379","article-title":"Clonal mast cell activation syndrome with anaphylaxis to sulfites","volume":"162","author":"Cifuentes","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.iac.2021.09.007_bib57","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jaip.2015.11.027","article-title":"alpha-Gal-a new clue for anaphylaxis in mastocytosis","volume":"4","author":"Roenneberg","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.iac.2021.09.007_bib58","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.jaip.2020.05.044","article-title":"Low frequency of IgE-mediated food hypersensitivity in mastocytosis","volume":"8","author":"Jarkvist","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.iac.2021.09.007_bib59","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/all.12617","article-title":"Drug hypersensitivity in clonal mast cell disorders: ENDA\/EAACI position paper","volume":"70","author":"Bonadonna","year":"2015","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2021.09.007_bib60","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/0310057X0903700415","article-title":"Anaphylactoid reaction to intravenous contrast in patient with systemic mastocytosis","volume":"37","author":"Weingarten","year":"2009","journal-title":"Anaesth Intensive Care"},{"issue":"5","key":"10.1016\/j.iac.2021.09.007_bib61","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s12630-011-9472-z","article-title":"Case report: perioperative immediate hypersensitivity involves not only allergy but also mastocytosis","volume":"58","author":"Renauld","year":"2011","journal-title":"Can J Anaesth"},{"issue":"1","key":"10.1016\/j.iac.2021.09.007_bib62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1710-1492-10-19","article-title":"Non-steroidal anti-inflammatory drug hypersensitivity: association with elevated basal serum tryptase?","volume":"10","author":"Seitz","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"9","key":"10.1016\/j.iac.2021.09.007_bib63","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/cea.12369","article-title":"The presence of mast cell clonality in patients with unexplained anaphylaxis","volume":"44","author":"Gulen","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.iac.2021.09.007_bib64","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","article-title":"A\u00a0distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis","volume":"141","author":"Carter","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2021.09.007_bib65","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajh.23672","article-title":"Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis","volume":"89","author":"Kristensen","year":"2014","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.iac.2021.09.007_bib66","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2021.09.007_bib67","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"issue":"8","key":"10.1016\/j.iac.2021.09.007_bib68","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/all.12437","article-title":"Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"issue":"1 Suppl","key":"10.1016\/j.iac.2021.09.007_bib69","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.amjmed.2013.09.008","article-title":"Recognition and first-line treatment of anaphylaxis","volume":"127","author":"Lieberman","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.iac.2021.09.007_bib70","first-page":"145","article-title":"Shock syndrome associated with mastocytosis: pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks","volume":"8","author":"Roberts","year":"1982","journal-title":"Adv Shock Res"},{"issue":"2","key":"10.1016\/j.iac.2021.09.007_bib71","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0091-6749(83)90098-2","article-title":"Intervention with epinephrine in hypotension associated with mastocytosis","volume":"71","author":"Turk","year":"1983","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2021.09.007_bib72","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.all.0000235902.02924.e9","article-title":"Emergency treatment and prevention of insect-sting anaphylaxis","volume":"6","author":"Clark","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2021.09.007_bib73","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.jaip.2019.07.005","article-title":"Anaphylaxis management: time to re-evaluate the role of corticosteroids","volume":"7","author":"Campbell","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2021.09.007_bib74","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/ACI.0000000000000377","article-title":"Pharmacotherapy of mast cell disorders","volume":"17","author":"Gulen","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2021.09.007_bib75","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jaci.2007.03.032","article-title":"Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis","volume":"119","author":"Carter","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2021.09.007_bib76","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/all.13237","article-title":"Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: efficacy and safety observations","volume":"73","author":"Broesby-Olsen","year":"2018","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.iac.2021.09.007_bib77","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM199202273260907","article-title":"Response to interferon alfa-2b in a patient with systemic mastocytosis","volume":"326","author":"Kluin-Nelemans","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.iac.2021.09.007_bib78","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000329218","article-title":"Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience","volume":"157","author":"Wimazal","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"issue":"26","key":"10.1016\/j.iac.2021.09.007_bib79","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","article-title":"Efficacy and safety of midostaurin in advanced systemic mastocytosis","volume":"374","author":"Gotlib","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.iac.2021.09.007_bib80","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1093\/annonc\/mdx290","article-title":"Midostaurin: a magic bullet that blocks mast cell expansion and activation","volume":"28","author":"Valent","year":"2017","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.iac.2021.09.007_bib81","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jaci.2020.03.044","article-title":"Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis","volume":"146","author":"Hartmann","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2021.09.007_bib82","first-page":"77","article-title":"Novel approaches to treating advanced systemic mastocytosis","volume":"11","author":"Gilreath","year":"2019","journal-title":"Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.iac.2021.09.007_bib83","doi-asserted-by":"crossref","first-page":"AB336","DOI":"10.1016\/j.jaci.2019.12.062","article-title":"PIONEER: a randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent or smoldering systemic mastocytosis (SM) with symptoms inadequately controlled by standard therapy","volume":"145","author":"Akin","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2021.09.007_bib84","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/j.jaip.2021.02.040","article-title":"Systemic mastocytosis with an associated hematologic neoplasm complicated by recurrent anaphylaxis: prompt resolution of anaphylaxis with the addition of avapritinib","volume":"9","author":"Kudlaty","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2021.09.007_bib85","article-title":"Distinct plasma biomarkers confirm the diagnosis of mastocytosis and identify increased risk of anaphylaxis","volume":"2","author":"G\u00fclen","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856121000825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856121000825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:45:10Z","timestamp":1760179510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856121000825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0889856121000825"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2021.09.007","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anaphylaxis and Mast Cell Disorders","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2021.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}